Emerging Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma

Hepatocellular carcinoma is the most common primary liver cancer and the fourth leading cause of cancer death worldwide. A total of 70–80% of patients are diagnosed at an advanced stage with a dismal prognosis. Sorafenib had been the standard care for almost a decade until 2018 when the Food and Dru...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Medicina (Kaunas)
Prif Awduron: Longo, Vito, Brunetti, Oronzo, Gnoni, Antonio, Licchetta, Antonella, Delcuratolo, Sabina, Memeo, Riccardo, Solimando, Antonio Giovanni, Argentiero, Antonella
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: MDPI 2019
Pynciau:
Review
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6843273/
https://ncbi.nlm.nih.gov/pubmed/31627433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medicina55100698
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg